SS

Subhash Sopanrao Suryawanshi

Active Director Director DIN 06922285
DIN 06922285 First appointment Sep 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Total affiliations 5 Since Sep 2014
Shareholding value •••• Premium profile

About Subhash Sopanrao Suryawanshi

Data last updated:

Subhash Sopanrao Suryawanshi is a Director at Ardent Life Sciences Private Limited (since 2014), Director at Ardentlife Pharmaceutical Private Limited (since 2024) and Director at Ardentlifecare Formulation Private Limited (since 2024), and holds 2 more current directorships. The companies operate in Pharma and Paper. The largest current company by reported revenue is Ardent Life Sciences Private Limited at ₹13.53 Cr (FY 2024).

DIN 06922285
Primary Designation Director
Industry Pharma
First Appointment 01 Sep 2014
Oldest Company Age 12 yrs
Largest company Ardent Life Sciences Private Limited · ₹13.53 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ardent Life Sciences Private Limited U24100PN2014PTC152374
Director01 Sep 20142014₹13.53 Cr (FY 2024)Active
Director05 Jul 20242024Active
Director24 Apr 20242024Active
Designated Partner23 Mar 20172017Active
Designated Partner04 Jan 20162016Active

Directorship timeline

Open interactive timeline →
Ardent Life Sciences Private Limited
Carrel Pharmaceuticals Llp
Arki Pharmaceuticals Llp
Ardentlife Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Subhash Sopanrao Suryawanshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subhash Sopanrao Suryawanshi

Subhash Sopanrao Suryawanshi currently holds 5 directorships: Ardent Life Sciences Private Limited (Director, since 01 Sep 2014, revenue ₹13.53 Cr (FY 2024)); Ardentlife Pharmaceutical Private Limited (Director, since 05 Jul 2024); Ardentlifecare Formulation Private Limited (Director, since 24 Apr 2024); Arki Pharmaceuticals Llp (Designated Partner, since 23 Mar 2017); Carrel Pharmaceuticals Llp (Designated Partner, since 04 Jan 2016).

Subhash Sopanrao Suryawanshi was first appointed on 01 Sep 2014 as Director at Ardent Life Sciences Private Limited. The most recent appointment on record is 05 Jul 2024 at Ardentlife Pharmaceutical Private Limited.

The current boards of Subhash Sopanrao Suryawanshi's companies include Sheetal Subhash Suryawanshi (Ardent Life Sciences Private Limited), Supriya Baran Chanda (Ardentlife Pharmaceutical Private Limited), Vijay Singh Patel (Ardentlife Pharmaceutical Private Limited), Nanasaheb Prabhakarrao Dhavan (Arki Pharmaceuticals Llp), Deepti Rajeev Bhasin (Carrel Pharmaceuticals Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available